An Institutional Review Board (IRB) is an independent committee designated by National Jewish Health to review, to approve the initiation of, and to conduct periodic review of research involving human subjects. The primary purpose of such review is to assure the protection of the rights and welfare of the human subjects. The IRB acts as an advocate for the research subject.
The National Jewish Health IRB website is designed to assist investigators and research staff with information on the regulatory procedures and requirements for conducting human subject research.
Review the Submissions section to get started.
Common Rule Change
National Jewish Health Human Research Protection Program (HRPP) is pleased to provide you some initial guidance regarding the Common Rule Change that will affect all human subjects research covered under the National Jewish Health assurance.
View Common Rule Change
In addition, on the following dates, the National Jewish Health HRPP staff will be offering educational sessions to National Jewish Health study teams in Heitler Hall:
- November 28th 2pm
- December 19th, 2pm
As we get closer to January, the HRPP Office will advise you on the processes we will have in place to ensure as smooth a transition as possible so that all research approved on or after 1/21/19 is fully compliant with the new Common Rule.
Research Regulatory Affairs
National Jewish Health
1400 Jackson Street, Room M211
Denver, CO 80206
Federalwide Assurance and IRB Registration
Federal-wide Assurance #: FWA00000778, expires August 1, 2019.
IRB Registration #: IORG0000018, expires January 26, 2021.
For information about National Jewish Health Federalwide Assurance, IRB Registration, and general organization, download our Letter of Assurance (PDF).
The IRB roster was last modified February 15, 2018. View a redacted roster (PDF).